Literature DB >> 17714777

Sulfated chitooligosaccharides as prolyl endopeptidase inhibitor.

Jae-Young Je1, Eun-Kyung Kim, Chang-Bum Ahn, Sang-Ho Moon, Byong-Tae Jeon, Bokyung Kim, Tae-Kyu Park, Pyo-Jam Park.   

Abstract

Prolyl endopeptidase (PEP, EC 3.4.21.26) is a proline-specific endopeptidase with a serine-type mechanism, which digests small peptide-like hormones, neuroactive peptides, and various cellular factors. PEP has been involved in neurodegenerative disorders, therefore, the discovery of PEP inhibitors can revert memory loss caused by amnesic compounds. In this study, we prepared hetero-chitooligosaccharides (COSs) with different molecular sizes using ultrafiltration (UF) membrane reactor system from hetero-chitosan with different degrees of deacetylation (DD; 90%, 75% and 50% deacetylation), and synthesized sulfated COSs (SCOSs). PEP inhibitory activities of SCOSs were evaluated and the results showed that 50% deacetylated SCOSs (50-SCOSs) exhibited higher inhibitory activities than those of 90% and 75% deacetylated SCOSs (90-SCOSs and 75-SCOSs). Among the 50-SCOSs (50-SCOS I, 5000-10,000Da; 50-SCOS II, 1000-5000Da; 50-SCOS III, below 1000Da), 50-SCOS II possessed the highest inhibitory activity and IC(50) value was 0.38mg/ml. Kinetics studies with 50-SCOS II indicated a competitive enzyme inhibition with a K(i) value of 0.78mg/ml. It was concluded that the 50-SCOS II may be useful for PEP inhibitor and for developing a new type PEP inhibitor from carbohydrate based materials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714777     DOI: 10.1016/j.ijbiomac.2007.07.003

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  3 in total

1.  Membrane bioreactor technology for the development of functional materials from sea-food processing wastes and their potential health benefits.

Authors:  Se-Kwon Kim; Mahinda Senevirathne
Journal:  Membranes (Basel)       Date:  2011-10-25

Review 2.  Chitooligosaccharide and its derivatives: preparation and biological applications.

Authors:  Gaurav Lodhi; Yon-Suk Kim; Jin-Woo Hwang; Se-Kwon Kim; You-Jin Jeon; Jae-Young Je; Chang-Bum Ahn; Sang-Ho Moon; Byong-Tae Jeon; Pyo-Jam Park
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

Review 3.  The Microstructure, Antibacterial and Antitumor Activities of Chitosan Oligosaccharides and Derivatives.

Authors:  Dawei Yu; Jiayao Feng; Huimin You; Shipeng Zhou; Yan Bai; Jincan He; Hua Cao; Qishi Che; Jiao Guo; Zhengquan Su
Journal:  Mar Drugs       Date:  2022-01-13       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.